Iaso Biotherapeutics, a Chinese cell therapy developer focusing on oncology treatments, has raised nearly CNY 500m (USD 75m) in an extended Series C round.
Eleven local investors took part in this round, including Shanghai Guoxin Investment & Development, Efung Capital, Shanghai Waigaoqiao Free Trade Zone Group, Nanjing Jiangbei New Area State-owned Asset...
IMM Investment is providing KRW 150bn (USD 121m) in Series A funding for Korean cloud computing business NHN Cloud at a valuation of KRW 1trn.
QuantaSing Group, a Chinese adult tuition platform that spun out from wealth management and investment education business Erwan Technology, has traded relatively flat following a USD 41m IPO on NASDAQ.
MBK Partners and Unison Capital Korea have launched a tender offer for Osstem Implant, a Korea-based manufacturer of dental implants, that values the company at approximately KRW 2.85trn (USD 2.3bn).
A Bain Capital-backed take-private of Japanese one-stop field marketing services provider Impact HD, which values the company at approximately JPY 30.7bn (USD 236.3m), has won board support.